฿125.00
+฿0.67(+0.53%)
data.updated
v2.stock.overview v2.daily.trading v2.range.52w
key.stats
yesterday.close฿124.33
market.size฿35.88B
volume.trade1.98M
pe.ratio31.78
div.yield0.59%
div.amount฿0.25
diluted.eps4.99
net.income฿1.30B
revenue฿6.94B
earnings.date2026-08-26
eps.estimate1.47
rev.estimate฿1.84B
shares.out288.63M
beta1.256
ex.div.date2026-06-30
div.pay.date2026-07-22
about.stock
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
sectorHealthcare
industryMedical - Diagnostics & Research
ceoPadraig McDonnell
headquartersSanta Clara,CA,US
websitehttps://www.agilent.com
employees18.10K
avg.revenue฿383.86K
income.per.emp฿71.98K
เรียนรู้เพิ่มเติมเกี่ยวกับ Agilent Technologies Inc (A)
blog.articles
GAS and US LNG Exports: How America Became a Key Swing SupplierAn in-depth analysis of GAS and US LNG exports, exploring how America became a swing supplier and what it means for global energy markets.2026-06-19

After RE is listed on multiple exchanges, will the on-chain insurance sector enter a new growth cycle?RE has recently been listed on Gate and other major exchanges, sparking renewed interest in the on-chain insurance sector. As stablecoins, real-world assets (RWA), and institutional capital continue to flow into the crypto market, the question of whether insurance and reinsurance infrastructure will enter a new phase of development is becoming a hot topic in the industry.2026-06-19

XAU in a High-Rate World: Can Gold Stay Strong Without Yield?An in-depth analysis of XAU in a high-rate world, exploring why gold can stay strong without yield and what shapes future demand.2026-06-18

stock.faq
stock.price
x
current.stats
52w.range.q
x
pe.ratio.q
x
market.cap.q
x
eps.recent.q
x
buy.sell.q
x
price.factors
x
buy.how
x
risk.warn
risk.notice
disclaimer2
risk.disclosure






